GE HealthCare Technologies Inc. (GEHC) announced the pricing of secondary underwritten public offering of 15 million shares of its common stock at a public offering price of $86.00 per share. The Offering was upsized from the previously announced offering size of 10 million GEHC Shares.GE HealthCare said it is not selling any shares of common stock and will not receive any proceeds from the sale of the GEHC Shares in the Offering or from the debt-for-equity exchange.The selling stockholder in the Offering has granted the underwriters an option to purchase 2.25 million additional shares of GE HealthCare common stock for settlement on or before September 30, 2024..

GE HealthCare Technologies Inc.（GEHC）宣布以每股86.00美元的公开发行价格对其1500万股普通股进行二次承销公开发行定价。此次发行规模比之前宣布的1000万股GEHC股票的发行规模有所扩大。GE HealthCare表示，它不会出售任何普通股，也不会从发售中出售GEHC股份或债转股中获得任何收益。。。

Morgan Stanley and Citigroup are acting as the lead joint book-running managers for the Offering. The Offering is expected to close on September 16, 2024. For comments and feedback contact: editorial@rttnews.comBusiness News

。如需评论和反馈，请联系：editorial@rttnews.comBusiness新闻

Biotech Stocks Facing FDA Decision In August 2024

2024年8月美国食品和药物管理局（FDA）决定生物技术股

Biotech Stocks Facing FDA Decision In June 2024

2024年6月美国食品和药物管理局（FDA）决定生物技术股

Biotech Stocks Facing FDA Decision In April 2024

2024年4月美国食品和药物管理局（FDA）决定生物技术股